查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2086161

整形外科生物製藥市場：2026-2032年全球市場預測（依產品類型、原料、製劑、作用機制、應用、最終用戶及通路分類）

Orthobiologics Market by Product Type, Source, Formulation, Mechanism of Action, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，整形外科生物製藥市場將成長至 103.7 億美元，複合年成長率為 5.91%。

主要市場統計數據
基準年 2025 69.4億美元
預計年份：2026年 73.4億美元
預測年份 2032 103.7億美元
複合年成長率 (%) 5.91%

整形外科生物製藥市場概覽

整形外科生物來源是生物衍生或仿生產品，用於支持整形外科手術、運動醫學、脊椎治療、創傷治療和再生醫學領域中骨骼、軟骨、肌腱、韌帶和軟組織的修復。此類別包括同種異體移植、脫礦骨基質、骨移植替代物、濃縮血小板血漿、骨髓抽吸物濃縮液、基於生長因子的溶液和支架技術。

整形外科生物製藥市場的變革性變化

整形外科生物製藥領域正從以手術技術主導的引進模式轉向以實證醫學為基礎、以療效為導向的商業化模式。醫院、門診手術中心和整形外科專家在評估產品時，不僅關注其新穎性，也越來越重視其臨床持久性、感染風險、移植物處理、醫療保險報銷以及術後恢復情況。

人工智慧（AI）的累積影響

人工智慧（AI）並非取代臨床判斷，而是正成為整形外科生物製藥領域的一股實際驅動力。 AI驅動的影像分析有助於根據骨骼質量、缺損大小、軟骨缺失、骨折類型和延遲癒合風險對患者進行分層。這些工具能夠支援更精準的產品選擇，並更好地與生物機制、手術技術和患者生物學特徵相匹配。

對關鍵區域的洞察

亞太地區是整形外科生物製藥領域最具活力的地區之一，這主要得益於日本、中國、韓國和澳洲人口老化、印度和東南亞整形外科基礎設施的不斷完善，以及創傷、脊椎和關節重組手術數量的成長。中國和印度憑藉龐大的病患群體和不斷完善的私人醫療體系，正在擴大其市場規模；而日本和澳洲則專注於臨床品質、最佳化保險報銷和先進的手術技術。韓國憑藉其技術先進的醫院和對再生醫學日益成長的興趣，進一步提升了該地區骨科生物製藥的市場潛力。

關鍵小組洞察

東協地區的需求成長主要得益於私立醫院的擴張、泰國和馬來西亞的醫療旅遊，以及新加坡作為臨床、監管和物流中心的地位。整形外科專科醫療、外科訓練和分銷網路完善的地區，骨科手術的普及程度最高。海灣合作理事會（GCC）市場則受益於國家醫療改革計劃、對高階醫院的投資，以及對運動傷害、脊椎、創傷和關節手術日益成長的需求。

主要國家的概況

美國是全球最大的創新和商業化中心，這得益於其龐大的整形外科手術量、FDA監管的產品核可流程、領先的學術研究機構、先進的組織庫以及對運動醫學的積極應用。加拿大憑藉其規範的公共醫療保健體系和實證醫學的採購方式，預計將擁有穩定的需求。墨西哥則受益於私立醫院、跨境醫療保健以及整形外科專科的進步。巴西是拉丁美洲最具影響力的市場，這得益於其龐大的市場規模、對私人醫療保健的投資以及對肌肉骨骼手術的強勁需求。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床驗證的整形外科生物製藥產品組合，這些產品組合應在適應症、作用機制、操作特性和治療效果證據方面具有顯著差異。企業應投資於前瞻性研究、註冊登記和真實世界證據（RWE）項目，以證明骨癒合率、疼痛緩解、功能恢復、避免再次手術、安全性和成本效益。

調查方法

本執行摘要基於二手研究方法，參考了公開檢驗的資訊來源，包括監管指南、國家衛生統計數據、科學文獻、醫院採購趨勢、臨床註冊資訊以及醫療保健政策更新。主要參考架構包括美國FDA的HCT/P分類、歐洲醫療設備法規（MDR）的要求、世界衛生組織（WHO）的肌肉骨骼疾病數據、國家整形外科使用指標以及關於生物整形外科干預措施的同行評審證據。

結論

整形外科生物製藥市場正從最初對再生醫學的熱情轉向以實證醫學主導成長。人口老化、肌肉骨骼疾病負擔加重、整形外科手術需求以及對更快康復的追求，持續推動脊椎、創傷、運動醫學、關節保護和重組手術等領域的長期應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章整形外科生物製藥市場：依產品類型分類

  • 黏彈性補充劑
  • 去礦物質骨基質
  • 富血小板血漿
    • 白血球富集 PRP
    • 白血球去除富血小板血漿
    • 純 PRP
  • 幹細胞
    • 造血系統
    • 間質
  • 合成骨替代物
    • 生物活性玻璃
    • 磷酸鈣
      • 羥磷石灰
      • 磷酸三鈣
    • 硫酸鈣

第8章整形外科生物製藥市場：依原料分類

  • 本土種植
    • 骨髓
    • 脂肪組織
  • 同種
  • 不同起源
    • 牛
    • 豬
  • 合成

第9章整形外科生物製藥市場：以劑型分類

  • 注射藥物
    • 液體
    • 凝膠
  • 固體的
    • 堵塞
    • 顆粒
    • 鷹架
  • 油灰
  • 貼上

第10章：整形外科生物製藥市場：依作用機制分類

  • 骨骼形成
  • 骨誘導
  • 骨傳導

第11章整形外科生物製藥市場：按應用領域分類

  • 脊椎固定
    • 頸椎融合術
    • 胸椎融合術
    • 腰椎融合術
  • 創傷修復
    • 上肢
    • 下肢
  • 重組手術
  • 運動傷害
    • 肌腱損傷
    • 韌帶損傷
    • 軟骨修復
  • 退化性疾病
  • 牙科用途

第12章整形外科生物製藥市場：依最終用戶分類

  • 醫院
    • 民眾
    • 私人的
  • 整形外科診所
  • 研究和學術機構
  • 復健中心

第13章整形外科生物製藥市場：依通路分類

  • 離線
  • 線上

第14章整形外科生物製藥市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章整形外科生物製藥市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章整形外科生物製藥市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • AlloSource
  • Alphatec Holdings Inc
  • Anika Therapeutics Inc
  • Arthrex Inc
  • Baxter International Inc
  • Bioventus LLC
  • Bone Biologics Corporation
  • BoneSupport AB
  • Cerapedics Inc
  • Collagen Matrix Inc
  • Globus Medical Inc
  • Integra LifeSciences Holdings Corporation
  • Isto Biologics
  • Johnson & Johnson Services Inc
  • Kuros Biosciences AG
  • LifeNet Health
  • Medtronic plc
  • NuVasive Inc
  • Organogenesis Holdings Inc
  • Orthofix Medical Inc
  • RTI Surgical Inc
  • Seaspine Holdings Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • Vericel Corporation
  • Xtant Medical Holdings Inc
  • Zimmer Biomet Holdings Inc
Product Code: MRR-036C5CF3B4C3

The Orthobiologics Market is projected to grow by USD 10.37 billion at a CAGR of 5.91% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.94 billion
Estimated Year [2026] USD 7.34 billion
Forecast Year [2032] USD 10.37 billion
CAGR (%) 5.91%

Orthobiologics Market Introduction

Orthobiologics are biologically derived or biomimetic products used to support bone, cartilage, tendon, ligament, and soft-tissue repair across orthopedic surgery, sports medicine, spine care, trauma, and regenerative medicine. The category includes allografts, demineralized bone matrices, bone graft substitutes, platelet-rich plasma, bone marrow aspirate concentrate, growth factor-based solutions, and scaffold technologies.

Demand for orthobiologics is anchored in verified healthcare fundamentals: the World Health Organization identifies musculoskeletal conditions as a leading contributor to disability worldwide, and global aging, osteoarthritis prevalence, fracture incidence, and rising orthopedic procedure volumes continue to expand the addressable patient pool. At the same time, regulatory scrutiny is increasing, especially for minimally manipulated human cells, tissues, and cellular and tissue-based products, making evidence generation, manufacturing quality, traceability, and clinical outcomes central to competitive advantage.

Transformative Shifts in the Orthobiologics Landscape

The orthobiologics landscape is shifting from procedure-driven adoption toward evidence-based, outcome-focused commercialization. Hospitals, ambulatory surgery centers, and orthopedic specialists are increasingly evaluating products on clinical durability, infection risk, graft handling, reimbursement alignment, and post-operative recovery outcomes rather than novelty alone.

Several structural shifts are reshaping the market. Spinal fusion and trauma applications continue to support demand for bone graft substitutes and allografts, while sports medicine and joint preservation are increasing interest in platelet-rich plasma and cell-concentrate workflows. Regulatory frameworks such as the U.S. FDA's distinction between Section 361 and Section 351 HCT/Ps and Europe's Medical Device Regulation are raising the bar for product claims, documentation, clinical evidence, and post-market surveillance. These changes favor manufacturers with strong clinical data, compliant processing, physician education, and robust quality systems.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical accelerator in orthobiologics rather than a replacement for clinical judgment. AI-enabled imaging analytics can help stratify patients by bone quality, defect size, cartilage loss, fracture pattern, and risk of delayed union. These tools support more precise product selection and can improve alignment between biologic mechanism, surgical technique, and patient biology.

AI also strengthens the commercial and operational foundation of orthobiologics. Machine learning can support donor tissue screening, batch-level quality analytics, inventory planning, adverse-event signal detection, and real-world evidence generation from registries and electronic health records. As regulators and payers demand stronger proof of safety and value, AI-enabled data pipelines can shorten feedback cycles, improve post-market monitoring, and help substantiate differentiated claims with clinically meaningful evidence.

Key Regional Insights

Asia-Pacific is one of the most dynamic orthobiologics regions, supported by aging populations in Japan, China, South Korea, and Australia; expanding orthopedic infrastructure in India and Southeast Asia; and rising procedure volumes for trauma, spine, and joint reconstruction. China and India add scale through large patient populations and increasing private healthcare capacity, while Japan and Australia emphasize clinical quality, reimbursement discipline, and advanced surgical practice. South Korea's technology-forward hospitals and regenerative medicine interest further strengthen regional adoption potential.

North America remains a high-value region due to established orthopedic procedure volumes, advanced biologics adoption, strong surgeon specialization, and mature tissue banking infrastructure. The United States leads in product innovation, clinical research, and FDA-regulated pathways, while Canada emphasizes regulated adoption within publicly funded care systems. Latin America, led by Brazil and Mexico, is progressing through private hospital networks, sports medicine demand, expanding orthopedic specialization, and medical tourism, although reimbursement variability and uneven access affect uptake.

Europe is shaped by strict regulatory expectations under the Medical Device Regulation, strong national health systems, and specialty orthopedic centers in Germany, France, Italy, Spain, and the United Kingdom. The Middle East, particularly GCC markets, is investing in orthopedic centers of excellence, private healthcare, and medical tourism, supporting demand for trauma, spine, and sports injury solutions. Africa remains underpenetrated but clinically important, with trauma care, infection control, affordability, and access to safe graft materials defining near-term opportunities across public and private care settings.

Key Group Insights

ASEAN demand is supported by expanding private hospitals, medical tourism in Thailand and Malaysia, and Singapore's role as a clinical, regulatory, and logistics hub. Adoption is strongest where orthopedic subspecialty care, surgeon training, and distributor networks are well developed. GCC markets are benefiting from national healthcare transformation programs, premium hospital investments, and rising demand for sports injury, spine, trauma, and joint procedures.

The European Union is defined by harmonized but demanding regulatory expectations, strong registry culture, and increasing emphasis on real-world evidence, clinical documentation, and post-market surveillance. BRICS markets offer patient scale, domestic manufacturing ambitions, and rising orthopedic access, with China, India, and Brazil particularly important due to hospital modernization, private healthcare expansion, and musculoskeletal disease burden. G7 countries remain central to orthobiologics innovation because of advanced research ecosystems, aging demographics, high orthopedic utilization, and sophisticated reimbursement assessment. NATO markets, while not a healthcare bloc, share defense medicine priorities relevant to trauma repair, reconstructive surgery, limb salvage, and dual-use regenerative technologies.

Key Country Insights

The United States is the largest innovation and commercialization hub, supported by orthopedic procedure volume, FDA-regulated product pathways, leading academic centers, advanced tissue banking, and active sports medicine adoption. Canada offers steady demand through regulated public health systems and evidence-based procurement, while Mexico benefits from private hospitals, cross-border care, and growing orthopedic specialization. Brazil is Latin America's most influential market, with scale, private healthcare investment, and strong musculoskeletal procedure demand.

In Europe, the United Kingdom combines NHS oversight with private orthopedic care, Germany leads through hospital infrastructure and medtech adoption, France emphasizes clinical governance and reimbursement assessment, Russia presents selective demand amid market access complexity, and Italy and Spain support adoption through spine, trauma, and sports medicine practices. China is expanding through hospital modernization, aging demographics, and domestic innovation; India is driven by trauma burden, affordability needs, orthopedic capacity expansion, and private care growth; Japan's aging population sustains demand for high-quality orthopedic solutions; Australia benefits from advanced sports medicine, joint care, and regulated clinical practice; and South Korea combines technology-forward hospitals with strong regenerative medicine interest.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically substantiated orthobiologics portfolios, with clear differentiation by indication, mechanism of action, handling profile, and outcomes evidence. Companies should invest in prospective studies, registry participation, and real-world evidence programs that demonstrate union rates, pain reduction, functional recovery, revision avoidance, safety, and cost-effectiveness.

Commercial execution should focus on surgeon education, compliant claims, supply reliability, and payer-aligned value messaging. Manufacturers should strengthen tissue sourcing transparency, biologic processing controls, cold-chain or inventory management where applicable, and post-market surveillance. Partnerships with orthopedic centers, ambulatory surgery networks, AI analytics providers, and regional distributors can accelerate adoption while preserving regulatory compliance and clinical credibility.

Research Methodology

This executive summary is developed using a secondary research approach grounded in publicly available, verifiable sources, including regulatory guidance, national health statistics, scientific literature, hospital procurement trends, clinical registries, and healthcare policy updates. Key reference frameworks include U.S. FDA HCT/P classifications, European Medical Device Regulation requirements, WHO musculoskeletal disease data, national orthopedic utilization indicators, and peer-reviewed evidence on biologic orthopedic interventions.

The methodology emphasizes triangulation across demand drivers, procedure settings, product categories, regulatory pathways, and regional healthcare systems. Insights are validated through consistency checks across clinical, commercial, and policy sources, with preference given to data-backed trends over speculative claims. Market interpretation focuses on adoption readiness, evidence strength, reimbursement feasibility, safety, traceability, and operational scalability.

Conclusion

The orthobiologics market is advancing from early regenerative enthusiasm toward disciplined, evidence-led growth. Aging populations, musculoskeletal disease burden, orthopedic procedure demand, and the pursuit of faster recovery continue to support long-term adoption across spine, trauma, sports medicine, joint preservation, and reconstructive applications.

The strongest opportunities will accrue to organizations that combine scientific credibility, regulatory discipline, manufacturing quality, and clinician trust. As artificial intelligence, real-world evidence, and precision patient selection mature, orthobiologics companies that prove measurable clinical and economic value will be best positioned to lead the next phase of orthopedic innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Orthobiologics Market, by Product Type

  • 7.1. Viscosupplements
  • 7.2. Demineralized Bone Matrix
  • 7.3. Platelet-Rich Plasma
    • 7.3.1. Leukocyte-Rich PRP
    • 7.3.2. Leukocyte-Poor PRP
    • 7.3.3. Pure PRP
  • 7.4. Stem Cell
    • 7.4.1. Hematopoietic
    • 7.4.2. Mesenchymal
  • 7.5. Synthetic Bone Substitutes
    • 7.5.1. Bioactive Glass
    • 7.5.2. Calcium Phosphate
      • 7.5.2.1. Hydroxyapatite
      • 7.5.2.2. Tricalcium Phosphate
    • 7.5.3. Calcium Sulfate

8. Orthobiologics Market, by Source

  • 8.1. Autologous
    • 8.1.1. Bone Marrow
    • 8.1.2. Adipose Tissue
  • 8.2. Allogeneic
  • 8.3. Xenogeneic
    • 8.3.1. Bovine
    • 8.3.2. Porcine
  • 8.4. Synthetic

9. Orthobiologics Market, by Formulation

  • 9.1. Injectable
    • 9.1.1. Liquid
    • 9.1.2. Gel
  • 9.2. Solid
    • 9.2.1. Blocks
    • 9.2.2. Granules
    • 9.2.3. Scaffolds
  • 9.3. Putty
  • 9.4. Paste

10. Orthobiologics Market, by Mechanism of Action

  • 10.1. Osteogenesis
  • 10.2. Osteoinduction
  • 10.3. Osteoconduction

11. Orthobiologics Market, by Application

  • 11.1. Spinal Fusion
    • 11.1.1. Cervical Fusion
    • 11.1.2. Thoracic Fusion
    • 11.1.3. Lumbar Fusion
  • 11.2. Trauma Repair
    • 11.2.1. Upper Extremities
    • 11.2.2. Lower Extremities
  • 11.3. Reconstructive Surgery
  • 11.4. Sports Injuries
    • 11.4.1. Tendon Injuries
    • 11.4.2. Ligament Injuries
    • 11.4.3. Cartilage Repair
  • 11.5. Degenerative Disorders
  • 11.6. Dental Applications

12. Orthobiologics Market, by End User

  • 12.1. Hospitals
    • 12.1.1. Public
    • 12.1.2. Private
  • 12.2. Orthopedic Clinics
  • 12.3. Research & Academic Institutes
  • 12.4. Rehabilitation Centers

13. Orthobiologics Market, by Distribution Channel

  • 13.1. Offline
  • 13.2. Online

14. Orthobiologics Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Orthobiologics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Orthobiologics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. AlloSource
  • 18.2. Alphatec Holdings Inc
  • 18.3. Anika Therapeutics Inc
  • 18.4. Arthrex Inc
  • 18.5. Baxter International Inc
  • 18.6. Bioventus LLC
  • 18.7. Bone Biologics Corporation
  • 18.8. BoneSupport AB
  • 18.9. Cerapedics Inc
  • 18.10. Collagen Matrix Inc
  • 18.11. Globus Medical Inc
  • 18.12. Integra LifeSciences Holdings Corporation
  • 18.13. Isto Biologics
  • 18.14. Johnson & Johnson Services Inc
  • 18.15. Kuros Biosciences AG
  • 18.16. LifeNet Health
  • 18.17. Medtronic plc
  • 18.18. NuVasive Inc
  • 18.19. Organogenesis Holdings Inc
  • 18.20. Orthofix Medical Inc
  • 18.21. RTI Surgical Inc
  • 18.22. Seaspine Holdings Corporation
  • 18.23. Smith & Nephew plc
  • 18.24. Stryker Corporation
  • 18.25. Vericel Corporation
  • 18.26. Xtant Medical Holdings Inc
  • 18.27. Zimmer Biomet Holdings Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL ORTHOBIOLOGICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ORTHOBIOLOGICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ORTHOBIOLOGICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ORTHOBIOLOGICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ORTHOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ORTHOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ORTHOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ORTHOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VISCOSUPPLEMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VISCOSUPPLEMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VISCOSUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PLATELET-RICH PLASMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PLATELET-RICH PLASMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PLATELET-RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LEUKOCYTE-RICH PRP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LEUKOCYTE-RICH PRP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LEUKOCYTE-RICH PRP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LEUKOCYTE-POOR PRP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LEUKOCYTE-POOR PRP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LEUKOCYTE-POOR PRP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PURE PRP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PURE PRP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PURE PRP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL STEM CELL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL STEM CELL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL STEM CELL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HEMATOPOIETIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEMATOPOIETIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HEMATOPOIETIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MESENCHYMAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MESENCHYMAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MESENCHYMAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SYNTHETIC BONE SUBSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SYNTHETIC BONE SUBSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SYNTHETIC BONE SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CALCIUM PHOSPHATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CALCIUM PHOSPHATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CALCIUM PHOSPHATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HYDROXYAPATITE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HYDROXYAPATITE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HYDROXYAPATITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL TRICALCIUM PHOSPHATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL TRICALCIUM PHOSPHATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL TRICALCIUM PHOSPHATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CALCIUM SULFATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CALCIUM SULFATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CALCIUM SULFATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AUTOLOGOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AUTOLOGOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AUTOLOGOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BONE MARROW MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BONE MARROW MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BONE MARROW MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ADIPOSE TISSUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ADIPOSE TISSUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ADIPOSE TISSUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ALLOGENEIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ALLOGENEIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ALLOGENEIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL XENOGENEIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL XENOGENEIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL XENOGENEIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BOVINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BOVINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BOVINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PORCINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PORCINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PORCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SYNTHETIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SYNTHETIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SYNTHETIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL LIQUID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL LIQUID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL LIQUID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SOLID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SOLID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SOLID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BLOCKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOCKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BLOCKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GRANULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GRANULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL GRANULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SCAFFOLDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SCAFFOLDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SCAFFOLDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PUTTY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PUTTY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PUTTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PASTE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PASTE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PASTE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL OSTEOGENESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL OSTEOGENESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL OSTEOGENESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL OSTEOINDUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL OSTEOINDUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL OSTEOINDUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL OSTEOCONDUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL OSTEOCONDUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL OSTEOCONDUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SPINAL FUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SPINAL FUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SPINAL FUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CERVICAL FUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CERVICAL FUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CERVICAL FUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL THORACIC FUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL THORACIC FUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL THORACIC FUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL LUMBAR FUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL LUMBAR FUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL LUMBAR FUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL TRAUMA REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL TRAUMA REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL TRAUMA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL UPPER EXTREMITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL UPPER EXTREMITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL UPPER EXTREMITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL LOWER EXTREMITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL LOWER EXTREMITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL LOWER EXTREMITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL RECONSTRUCTIVE SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL RECONSTRUCTIVE SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL RECONSTRUCTIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL SPORTS INJURIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL SPORTS INJURIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL SPORTS INJURIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL TENDON INJURIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL TENDON INJURIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL TENDON INJURIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL LIGAMENT INJURIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL LIGAMENT INJURIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL LIGAMENT INJURIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL CARTILAGE REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL CARTILAGE REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL CARTILAGE REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL DEGENERATIVE DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL DEGENERATIVE DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL DEGENERATIVE DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL DENTAL APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL DENTAL APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL DENTAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL PUBLIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL PUBLIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL PUBLIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL PRIVATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL PRIVATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL PRIVATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL ORTHOPEDIC CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL ORTHOPEDIC CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL ORTHOPEDIC CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE ORTHOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
  • TABLE 264. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2018-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 266. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2018-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 268. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2018-2032 (USD MILLION)
  • TABLE 270. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 272. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 274. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 276. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2018-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2018-2032 (USD MILLION)
  • TABLE 278. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 280. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 281. AFRICA ORTHOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 282. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
  • TABLE 284. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2018-2032 (USD MILLION)
  • TABLE 285. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 286. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2018-2032 (USD MILLION)
  • TABLE 287. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 288. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
  • TABLE 289. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2018-2032 (USD MILLION)
  • TABLE 290. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 291. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 292. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 293. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 294. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 296. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2018-2032 (USD MILLION)
  • TABLE 297. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2018-2032 (USD MILLION)
  • TABLE 298. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 300. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 301. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 302. ASEAN ORTHOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 303. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
  • TABLE 305. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2018-2032 (USD MILLION)
  • TABLE 306. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 307. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2018-2032 (USD MILLION)
  • TABLE 308. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 309. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
  • TABLE 310. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2018-2032 (USD MILLION)
  • TABLE 311. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 312. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 313. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 314. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 315. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 316. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 317. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2018-2032 (USD MILLION)
  • TABLE 318. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2018-2032 (USD MILLION)
  • TABLE 319. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 320. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 321. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 322. GCC ORTHOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 323. GCC ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 324. GCC ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
  • TABLE 325. GCC ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2018-2032 (USD MILLION)
  • TABLE 326. GCC ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 327. GCC ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2018-2032 (USD MILLION)
  • TABLE 328. GCC ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 329. GCC ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
  • TABLE 330. GCC ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2018-2032 (USD MILLION)
  • TABLE 331. GCC ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 332. GCC ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 333. GCC ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 334. GCC ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 335. GCC ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 336. GCC ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 337. GCC ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2018-2032 (USD MILLION)
  • TABLE 338. GCC ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2018-2032 (USD MILLION)
  • TABLE 339. GCC ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 340. GCC ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 341. GCC ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 342. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 343. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 344. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
  • TABLE 345. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2018-2032 (USD MILLION)
  • TABLE 346. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 347. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2018-2032 (USD MILLION)
  • TABLE 348. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 349. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
  • TABLE 350. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2018-2032 (USD MILLION)
  • TABLE 351. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 352. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 353. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 354. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 355. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 356. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 357. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2018-2032 (USD MILLION)
  • TABLE 358. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2018-2032 (USD MILLION)
  • TABLE 359. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 360. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 361. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 362. BRICS ORTHOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 363. BRICS ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 364. BRICS ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
  • TABLE 365. BRICS ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2018-2032 (USD MILLION)
  • TABLE 366. BRICS ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 367. BRICS ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2018-2032 (USD MILLION)
  • TABLE 368. BRICS ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 369. BRICS ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
  • TABLE 370. BRICS ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2018-2032 (USD MILLION)
  • TABLE 371. BRICS ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 372. BRICS ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 373. BRICS ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 374. BRICS ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 375. BRICS ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 376. BRICS ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 377. BRICS ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2018-2032 (USD MILLION)
  • TABLE 378. BRICS ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2018-2032 (USD MILLION)
  • TABLE 379. BRICS ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 380. BRICS ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 381. BRICS ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 382. G7 ORTHOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 383. G7 ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 384. G7 ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
  • TABLE 385. G7 ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2018-2032 (USD MILLION)
  • TABLE 386. G7 ORTHOBIOLOGICS MARKET SIZE,